Perrigo Company Profile



Odds of Distress

Check how we calculate scores
Equity ratings for Perrigo Company plc are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 26, 2019 and ending today August 25, 2019. Click here to learn more.
USD 1.43  2.99%

Perrigo Company Summary

Perrigo Company plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 6.4B. Perrigo Company conducts business under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 135.99M outstanding shares of which 8.32M shares are at this time shorted by private and institutional investors with about 7.83 trading days to cover. PERRIGO COMPANY currently holds about 1.06B in cash with 325.59M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.78.
Check Perrigo Company Probability Of Bankruptcy

Ownership Allocation (%)

Perrigo Company Target Price Odds Analysis

Odds Below 46.34HorizonTargetOdds Above 46.34
9.69%30 days 46.34 90.22%
Based on normal probability distribution, the odds of Perrigo Company to move above current price in 30 days from now is about 90.22% (This Perrigo Company plc probability density function shows the probability of Perrigo Company Stock to fall within a particular range of prices over 30 days) .

Perrigo Company Top Holders

Perrigo Company Risk Profiles

Perrigo Company Key Fundamentals

Perrigo Company Against Markets

Perrigo Company Vital Trading Data

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people. more
NamePerrigo Company plc
President CEO, DirectorMurray KesslerView All
Analyst Consensus
Macroaxis Advice
Bond Rating
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
Business AddressThe Sharp Building
Foreign Associate  Israel
ExchangeBATS Exchange
IndustryDrug Manufacturers - Specialty & Generic
Phone353 1 709 4000
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 29, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestJuly 31, 2019

Perrigo Company Corporate Directors

Gary Cohen Independent Director
Laurie Brlas Independent Director
Donal OConnor Independent Director
Additionally take a look at Your Equity Center. Please also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.